diagnostic

Pfizer will get FDA inexperienced mild for brand spanking new shot that may streamline youngsters’ vaccinations

Merck and Eisai say two lung-cancer trials failed to satisfy their major objectives

T2 Biosystems reaches regulatory milestone that may very well be a sport changer, analyst says

In Silicon Valley, a increase period feels prefer it’s ending

After IPO, Bausch + Lomb turns to an business favourite to run the corporate